Noam Erez - Infectious Diseases

Author Information

Noam Erez is an esteemed researcher affiliated with the Department of Infectious Diseases at the Israel Institute of Biological Research (IIBR) in Ness-Ziona, Israel. His work primarily focuses on the understanding and development of treatments and vaccines for infectious diseases, with particular attention to viral pathogens such as SARS-CoV-2 and influenza viruses.

Research Contributions

Noam Erez has made significant contributions in the field of infectious diseases, particularly in the study and development of vaccines against SARS-CoV-2. His research includes exploring the immunogenicity and safety of rVSV-ΔG-SARS-CoV-2-S vaccines in various animal models, as well as investigating the innate immune response to SARS-CoV-2. Additionally, Erez has studied the interactions between influenza and SARS-CoV-2, highlighting the role of influenza immunity in reducing co-infection lethality. His work extends to the evaluation of antiviral compounds and their effects on virus replication.

Aliases

Noam Erez is also known by the aliases N Erez and N. Erez. These variations may be used interchangeably in academic publications and citations.

Publication and Citation Metrics

Metric	Value
Total Citations	2936
H-index	25
Total Papers	106

Publications:

Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera

DOI: 10.3390/vaccines10020291

Year: 2022

Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection

DOI: 10.3390/v14020189

Year: 2022

Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs

DOI: 10.1007/s00204-021-03214-w

Year: 2022

Increased lethality in Influenza and SARS-CoV-2 co-infection is prevented by influenza immunity but not SARS-CoV-2 immunity

DOI: 10.21203/rs.3.rs-136702/v1

Year: 2021

Nonclinical Safety and Immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs

DOI: 10.1101/2021.07.06.451119

Year: 2021

Monitoring group activity of hamsters and mice as a novel tool to evaluate COVID-19 progression, convalescence and rVSV-ΔG-spike vaccination efficacy

DOI: 10.1101/2021.06.09.447687

Year: 2021

Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity

DOI: 10.1038/s41467-021-26113-1

Year: 2021

Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants

DOI: 10.1200/PO.21.00079

Year: 2021

Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus

DOI: 10.1016/j.jbc.2021.100470

Year: 2021

Spontaneous and Targeted Mutations in the Decapping Enzyme Enhance Replication of Modified Vaccinia Virus Ankara (MVA) in Monkey Cells

DOI: 10.1128/JVI.01104-21

Year: 2021

How Does Climate Change Influence the Spread of Infectious Diseases?

How is Schistosomiasis Transmitted?

How Do Antimicrobials Work?

Why is Co-Infection Clinically Significant?

What Treatments are Available for Dengue?

What is the Global Impact of West Nile Virus?

What are the clinical features of infections caused by Flaviviridae?

What is the Importance of International Collaboration?

What are the Common Barriers to Vaccination?

What is COVID-19?

Partnered Content Networks

Relevant Topics